FY2025 EPS Forecast for Cardinal Health Boosted by Analyst

Cardinal Health, Inc. (NYSE:CAH - Free Report) - Equities research analysts at Zacks Research raised their FY2025 EPS estimates for Cardinal Health in a report issued on Thursday, May 22nd. Zacks Research analyst R. Department now expects that the company will earn $8.09 per share for the year, up from their prior forecast of $7.88. The consensus estimate for Cardinal Health's current full-year earnings is $7.95 per share. Zacks Research also issued estimates for Cardinal Health's Q4 2025 earnings at $1.93 EPS, Q1 2026 earnings at $2.08 EPS, Q2 2026 earnings at $1.99 EPS, Q4 2026 earnings at $2.38 EPS, FY2026 earnings at $8.98 EPS, Q1 2027 earnings at $2.20 EPS, Q2 2027 earnings at $2.23 EPS, Q3 2027 earnings at $2.62 EPS and FY2027 earnings at $9.77 EPS.

Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The company reported $2.35 EPS for the quarter, beating analysts' consensus estimates of $2.15 by $0.20. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. The company had revenue of $54.88 billion during the quarter, compared to analysts' expectations of $55.33 billion. During the same period last year, the business posted $2.08 earnings per share. The firm's revenue was up .0% compared to the same quarter last year.

Several other research analysts have also recently issued reports on the company. Jefferies Financial Group upgraded Cardinal Health from a "hold" rating to a "buy" rating and raised their price objective for the stock from $140.00 to $150.00 in a research note on Wednesday, February 5th. Wall Street Zen upgraded shares of Cardinal Health from a "buy" rating to a "strong-buy" rating in a research note on Monday, May 5th. Mizuho increased their price objective on shares of Cardinal Health from $142.00 to $150.00 and gave the stock an "outperform" rating in a research note on Monday, March 31st. Robert W. Baird raised their target price on shares of Cardinal Health from $156.00 to $170.00 and gave the stock an "outperform" rating in a report on Friday, May 2nd. Finally, Wells Fargo & Company upped their price target on shares of Cardinal Health from $135.00 to $136.00 and gave the company an "equal weight" rating in a report on Tuesday, February 4th. Four equities research analysts have rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $146.43.

Cardinal Health Stock Performance

CAH stock traded up $0.52 during midday trading on Monday, reaching $154.51. The stock had a trading volume of 84,240 shares, compared to its average volume of 2,218,663. The firm has a fifty day simple moving average of $141.26 and a two-hundred day simple moving average of $130.05. The stock has a market cap of $36.88 billion, a PE ratio of 28.84, a P/E/G ratio of 1.49 and a beta of 0.66. Cardinal Health has a 52-week low of $93.17 and a 52-week high of $156.44.

Cardinal Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be issued a $0.5107 dividend. This represents a $2.04 annualized dividend and a yield of 1.32%. The ex-dividend date of this dividend is Tuesday, July 1st. This is a positive change from Cardinal Health's previous quarterly dividend of $0.51. Cardinal Health's payout ratio is presently 31.83%.

Institutional Trading of Cardinal Health

Institutional investors have recently modified their holdings of the stock. Geode Capital Management LLC increased its stake in Cardinal Health by 1.9% during the 4th quarter. Geode Capital Management LLC now owns 5,859,132 shares of the company's stock worth $691,145,000 after buying an additional 109,273 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in Cardinal Health by 40.0% during the 1st quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company's stock worth $575,327,000 after purchasing an additional 1,193,983 shares during the last quarter. Invesco Ltd. boosted its stake in Cardinal Health by 4.6% during the 4th quarter. Invesco Ltd. now owns 3,182,514 shares of the company's stock worth $376,396,000 after purchasing an additional 140,368 shares during the last quarter. Marshall Wace LLP grew its holdings in shares of Cardinal Health by 154.6% during the fourth quarter. Marshall Wace LLP now owns 3,151,736 shares of the company's stock worth $372,756,000 after buying an additional 1,913,892 shares in the last quarter. Finally, Northern Trust Corp raised its position in shares of Cardinal Health by 3.5% in the first quarter. Northern Trust Corp now owns 3,143,003 shares of the company's stock valued at $433,012,000 after buying an additional 105,154 shares during the last quarter. Institutional investors and hedge funds own 87.17% of the company's stock.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.